Search
Tagorizine
go.drugbank.com/drugs/DB20098ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Tagorizine is a antihistaminic/cerebral (or peripheral) vasodilator. Tagorizine has a monoisotopic molecular weight of 468.29 Da.
Belarizine
go.drugbank.com/drugs/DB20540ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Belarizine is a antihistaminic/cerebral (or peripheral) vasodilator. Belarizine has a monoisotopic molecular weight of 358.2 Da.
Trelnarizine
go.drugbank.com/drugs/DB21183ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Trelnarizine is a antihistaminic/cerebral (or peripheral) vasodilator. Trelnarizine has a monoisotopic molecular weight of 464.23 Da.
Domazoline
go.drugbank.com/drugs/DB19937ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Domazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Cintirorgon
go.drugbank.com/drugs/DB20916InvestigationalCintirorgon is under investigation in clinical trial NCT02929862 (Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer).
Coumazoline
go.drugbank.com/drugs/DB21226ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Coumazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
NBF-006
go.drugbank.com/drugs/DB21770InvestigationalNBF-006 is under investigation in clinical trial NCT03819387 (A Study of NBF-006 in Non-small Cell Lung, Pancreatic, or Colorectal Cancer).
Ontuxizumab
go.drugbank.com/drugs/DB16270InvestigationalOntuxizumab is a humanized monoclonal antibody that targets endosialin or tumour endothelial marker 1 (TEM-1).
Elzasonan
go.drugbank.com/drugs/DB18969InvestigationalElzasonan is under investigation in clinical trial NCT00275197 (A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive
Mevidalen
go.drugbank.com/drugs/DB19034InvestigationalMevidalen is under investigation in clinical trial NCT03305809 (A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or